27 August 2021: Clinical Research
A Prognostic Model of Gastrointestinal Diffuse Large B Cell Lymphoma
Fan Gao 1ACDEF , Zhan-fang Wang 2BCD , Lei Tian 1DF , Fei Dong 1BC , Jing Wang 1BD , Hong-mei Jing 1BD , Xiao-yan Ke 1AG*DOI: 10.12659/MSM.929898
Med Sci Monit 2021; 27:e929898
Figure 5 Comparison with the IPI score. (A) Risk stratification based on IPI score. (B) Comparison of high-risk group obtained with the HLAMA score and with the IPI score. (C) Comparison of intermediate-risk group obtained with the HLAMA score and with the IPI score. (D) Comparison of the low-risk group obtained with the HLAMA score and with the IPI score. (E) Comparison of low-risk group obtained with the HLAMA score and with the NCCN-IPI score. (F) Comparison of the high-risk group obtained with the HLAMA score and with the NCCN-IPI score.